Data protection Impressum

Life sciences

Scientists at the University of Fribourg have identified a molecular mechanism that keeps certain breast cancer cells dormant by stimulating the immune response, opening new therapeutic perspectives.

Fribourg researchers identify breast cancer dormancy mechanism

11 February 2026

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

SamanTree Medical has secured EUR 20 million from the European Investment Bank to expand its surgical imaging technology across Europe and the United States and accelerate product development.

SamanTree Medical secures EUR 20 million to scale surgical imaging technology

2 February 2026

ORamaVR has raised USD 4.5 million in late-seed funding to accelerate the commercial rollout of its AI-powered medical extended reality platform for surgical training and device simulation.

Geneva-based ORamaVR raises USD 4.5 million to scale medical XR training solutions

30 January 2026

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded CHF 50,000 grants to three academic spin-off projects from Geneva, supporting innovation in medical technology, scientific instrumentation, and gene therapy.

FIF awards grants to three Geneva-based academic spin-offs

29 January 2026

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

Geneva-based biotech start-up FluoSphera has raised CHF 1.15 million to expand its human-relevant preclinical testing platform, supporting the shift toward more predictive and non-animal drug development models.

FluoSphera raises CHF 1.15 million to scale human-based preclinical drug testing

19 January 2026

LEM Surgical presented its Dynamis robotic platform at CES 2026, highlighting its clinical deployment in the U.S. and outlining a new development roadmap integrating NVIDIA’s physical AI technologies.

LEM Surgical showcases its Dynamis robotic system and AI roadmap at CES 2026

19 January 2026

DigeHealth has raised CHF 1.25 million to accelerate the development of a wearable device that continuously monitors gastrointestinal activity using acoustics and artificial intelligence.

DigeHealth raises CHF 1.25 million to advance continuous gastrointestinal monitoring

15 December 2025

Seven medtech start-ups have been selected for the inaugural sitem-insel Innovation Voucher program, further strengthening the canton of Bern’s growing position as a hub for translational medicine and applied life sciences innovation.

sitem-insel launches Innovation Voucher to support emerging medtech companies

10 December 2025

1 2 3 4 5 … 47